PEN
Penumbra Inc · Healthcare · Market cap $12.7B
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$11.1M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Oct 16, 2026
Grewal Harpreet
Penumbra Inc (PEN) has 39 SEC Form 4 filings (73 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Oct 16, 2026.
Inside the rolling window, 5 insiders at Penumbra Inc reported no open-market purchases and 13 open-market sales totaling $11.1M. The most active filer is Director Grewal Harpreet with 4 filings. The most recent open-market filing is a sale of 100 shares by Director Grewal Harpreet, dated Apr 2, 2026, worth $33K.
- Industry:Medical - Devices
- CEO:Adam Elsesser
- Employees:4,700
- HQ:Alameda, CA, US
- IPO:2015-09-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 100 | $33K | Apr 6 | -1.9% | SEC ↗ | |
Yuen MaggieFirst in 3 months | Chief Financial Officer | Sale | 2,432 | $832K | Mar 4 | -4.7% | SEC ↗ |
| Director | Sale | 186 | $58K | Jan 8 | +2.5% | SEC ↗ | |
Wilder ThomasFirst filing | Director | Sale | 186 | $58K | Jan 6 | +2.1% | SEC ↗ |
| Director | Sale | 15,000 | $4.6M | Dec 15 | +4.7% | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 300 | $90K | Dec 9 | — | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 600 | $177K | Dec 3 | — | SEC ↗ | |
| Director | Sale | 100 | $29K | Dec 3 | — | SEC ↗ | |
| Director | Sale | 7,500 | $2.3M | Nov 26 | — | SEC ↗ | |
| EVP, Gen. Counsel & Secretary | Sale | 1,800 | $540K | Nov 26 | — | SEC ↗ | |
Bose AraniFirst filing | Director | Sale | 7,500 | $2.2M | Nov 25 | — | SEC ↗ |
Roberts JohannaFirst filing | EVP, Gen. Counsel & Secretary | Sale | 600 | $160K | Nov 12 | — | SEC ↗ |
Grewal HarpreetFirst filing | Director | Sale | 186 | $42K | Nov 6 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading PEN 7 all-time
- RRep. Lisa C. McClainOther$1,001 - $15,0002025-07-10
- DRep. Ro KhannaSale$1,001 - $15,0002022-06-27
- DRep. Ro KhannaPurchase$1,001 - $15,0002022-05-10
- DRep. Ro KhannaPurchase$1,001 - $15,0002022-05-05
- DRep. Ro KhannaSale$1,001 - $15,0002022-05-23
- DRep. Ro KhannaPurchase$1,001 - $15,0002022-01-21
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does PEN have?
Penumbra Inc (PEN) has 39 SEC Form 4 filings (73 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Oct 16, 2026.
When was the most recent SEC Form 4 filing for PEN?
The most recent Form 4 filing for PEN on Tracefour is dated Oct 16, 2026.
Who is the most active insider at PEN?
The most active SEC Form 4 filer at PEN in the rolling window is Director Grewal Harpreet, with 4 filings.
What is the total insider buy and sell value at PEN in the current window?
Inside the rolling window, insiders at PEN bought $0 and sold $11.1M based on SEC Form 4 filings.
Can I get alerts for PEN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Penumbra Inc (PEN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Penumbra Inc is in the Healthcare sector.